IFRS Financial statements Consolidated statement of cash flows For the year ended 31 December 2015 The cash flows presented in this statement cover all the Groups activities and include flows from both policyholder and shareholder activities.
All cash and cash equivalents are available for use by the Group.
2015 2014 Note m m 1 Cash flows from operating activities Cash generated from used in continuing operations 5,197 87 55a Tax paid 442 457 Net cash from used in operating activities - continuing operations 4,755 544 Total net cash from used in operating activities 4,755 544 Cash flows from investing activities Acquisitions of, and additions to, subsidiaries, joint ventures and associates, net of cash acquired 55b 7,783 79 Disposals of subsidiaries, joint ventures and associates, net of cash transferred 55c 3 110 New loans to joint ventures and associates 21 73 18a i Repayment of loans to joint ventures and associates 33 18 & 19 Net new loans to joint ventures and associates 21 40 Purchases of property and equipment 58 116 Proceeds on sale of property and equipment 51 19 Other cash flow related to intangible assets 111 122 Net cash from used in investing activities - continuing operations 7,641 228 2 Net cash from used in investing activities - discontinued operations 20 Total net cash from used in from investing activities 7,641 248 Cash flows from financing activities Redemption of Direct Capital Instrument 547 Proceeds from issue of ordinary shares 16 8 Treasury shares purchased for employee trusts 1 New borrowings drawn down, net of expenses 2,049 2,383 3 Repayment of borrowings 1,979 2,442 Net drawdown repayment of borrowings 70 59 49 Interest paid on borrowings 588 527 Preference dividends paid 17 17 15 4 Ordinary dividends paid 635 447 15 Coupon payments on the direct capital instruments and tier 1 notes 72 88 15 Capital contributions from non-controlling interests of subsidiaries 5 38 5 Dividends paid to non-controlling interests of subsidiaries 142 189 38 Changes in controlling interest in subsidiaries 1 89 Net cash used in financing activities - continuing operations 1,365 1,955 Total net cash used in financing activities 1,365 1,955 Total net increase decrease in cash and cash equivalents 11,031 2,747 Cash and cash equivalents at 1 January 22,564 25,989 Effect of exchange rate changes on cash and cash equivalents 425 678 Cash and cash equivalents at 31 December 33,170 22,564 55d 1 Cash flows from operating activities include interest received of 5,251 million 2014: 4,986 million and dividends received of 2,353 million 2014: 1,442 million.
2 Discontinued operations represent the results of the US life and related internal asset management businesses US Life sold in 2013.
3 Includes redemption of 2005 STICS of 268 million.
4 Ordinary dividends paid amounted to 635 million 2014: 449 million.
2 million of unclaimed and waived dividends has been set off against this above.
5 Dividends paid to non-controlling interests of subsidiaries included 7 million on the 2003 STICS and 17 million on the 2005 STICS prior to reclassification.
The accounting policies identified alphabetically on pages 133 to 146 and notes identified numerically on pages 154 to 269 are an integral part of the financial statements.
Aviva plc Annual report and accounts 2015 | 153 Aviva plc Annual report and accounts 2015 | 153
